Guru Ownership Trend
Guru Analysis for Stoke Therapeutics, Inc. (STOK)
Stoke Therapeutics, Inc. (STOK), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.71 M.
Top institutional holders include John Hussman and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $2.56 M net outflow during the quarter.
On the selling side, John Hussman reduced exposure by 50.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Stoke Therapeutics, Inc. (STOK)
Major holders include John Hussman ($1.37 M), Cliff Asness ($865,411). According to the latest reported data, 2 tracked investment managers collectively hold approximately 68,449 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $2.56 M, with 0 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited STOK. The total reported sell value was $2.56 M.
No tracked managers opened new positions or increased their holdings in STOK during the most recent reporting period.